Literature DB >> 10407810

[Persistent Lactobacillus casei subspecies rhamnosus bacteremia in a 14 year old girl with acute myeloid leukemia. A case report].

J Majcher-Peszynska1, W Heine, I Richter, G Eggers, C Mohr.   

Abstract

The present clinical observation is related to a 14-year-old girl suffering from acute myeloid leukemia. The clinical course was complicated by episodes of severe enterocolitis, E. coli- septicemia, pancreatitis and pneumonia. In the course of continued cytostatic and antibiotic treatment a persistent asymptomatic Lactobacillus casei subsp. rhamnosus-bacteremia became detectable by a total of 18 blood cultures. Microbial cultures of the faeces revealed colony-forming unites of this germ in orders of 10(9)/g. Antibiotic eradication attempts according to the resistogram were not successful. The Lactobacillus-bacteremia disappeared only after 13 months when the cytostatic therapy was terminated. An adjuvant influence of the Lactobacillus infection on the outcome of the underlying disease cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407810     DOI: 10.1055/s-2008-1043764

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  4 in total

1.  Lactobacillus rhamnosus bacteremia: an emerging clinical entity.

Authors:  F Gouriet; M Million; M Henri; P-E Fournier; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

Review 2.  Mechanisms and therapeutic effectiveness of lactobacilli.

Authors:  Alessandro Di Cerbo; Beniamino Palmieri; Maria Aponte; Julio Cesar Morales-Medina; Tommaso Iannitti
Journal:  J Clin Pathol       Date:  2015-11-17       Impact factor: 3.411

3.  Recurrent Lactobacillus Bacteremia in a Patient With Leukemia.

Authors:  Paurush Ambesh; Sarah Stroud; Eva Franzova; Joseph Gotesman; Kavita Sharma; Lawrence Wolf; Stephan Kamholz
Journal:  J Investig Med High Impact Case Rep       Date:  2017-11-24

Review 4.  Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer.

Authors:  Giuseppe L Banna; Francesco Torino; Francesco Marletta; Maria Santagati; Rossella Salemi; Elisa Cannarozzo; Luca Falzone; Francesco Ferraù; Massimo Libra
Journal:  Front Pharmacol       Date:  2017-09-01       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.